Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 Weeks in Subjects With Chronic Genotype 1 or 4 HCV and HIV-1 Co-infection

Last updated: October 19, 2018
Sponsor: Gilead Sciences
Overall Status: Completed

Phase

3

Condition

Hiv

Hepatitis

Liver Disorders

Treatment

N/A

Clinical Study ID

NCT02073656
GS-US-337-0115
  • Ages > 18
  • All Genders

Study Summary

This study will evaluate the antiviral efficacy, safety, and tolerability of ledipasvir/sofosbuvir (LDV/SOF) fixed-dose combination (FDC) administered for 12 weeks in hepatitis C virus (HCV) treatment-naive and treatment-experienced (including treatment intolerant) participants with chronic genotype 1 or 4 HCV infection who are co-infected with HIV-1.

Participants who experience confirmed post-treatment virologic failure (relapse) at or before Posttreatment Week 24 may be eligible to be enrolled in the Retreatment Substudy to receive LDV/SOF plus ribavirin (RBV) for 24 weeks.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • HCV RNA ≥ 10,000 IU/mL at screening

  • HCV genotype 1 or 4

  • HIV-1 infection

  • Cirrhosis determination, a fibroscan or liver biopsy may be required

  • Screening laboratory values within defined thresholds

  • Use of protocol specified method(s) of contraception if female of childbearingpotential or sexually active male

Exclusion

Exclusion Criteria:

  • Clinically-significant illness (other than HCV or HIV) or any other major medicaldisorder that may interfere with subject treatment, assessment, or compliance with theprotocol

  • Current or prior history of clinical hepatic decompensation, hepatocellular carcinoma (HCC), or other malignancy (with the exception of certain resolved skin cancers)

  • Hepatitis B virus (HBV) infection

  • Pregnant or nursing female

  • Chronic use of systemically administered immunosuppressive agents

Study Design

Total Participants: 335
Study Start date:
February 01, 2014
Estimated Completion Date:
December 31, 2015

Connect with a study center

  • Vancouver, British Columbia V6Z 1Y6
    Canada

    Site Not Available

  • Ottawa, Ontario K1H 8L6
    Canada

    Site Not Available

  • Toronto, Ontario M5G 2N2
    Canada

    Site Not Available

  • Montreal, Quebec H2L 5B1
    Canada

    Site Not Available

  • Auckland, 1142
    New Zealand

    Site Not Available

  • Christchurch, 8011
    New Zealand

    Site Not Available

  • San Juan, 00936-5607
    Puerto Rico

    Site Not Available

  • Birmingham, Alabama 35294-2170
    United States

    Site Not Available

  • Los Angeles, California 90027
    United States

    Site Not Available

  • Newport Beach, California 92663
    United States

    Site Not Available

  • Palo Alto, California 94304-5350
    United States

    Site Not Available

  • Sacramento, California 95817
    United States

    Site Not Available

  • San Diego, California 92103
    United States

    Site Not Available

  • San Francisco, California 94110
    United States

    Site Not Available

  • Torrance, California 90502
    United States

    Site Not Available

  • Denver, Colorado 80209
    United States

    Site Not Available

  • Washington, District of Columbia 20815
    United States

    Site Not Available

  • Bradenton, Florida 34209
    United States

    Site Not Available

  • Miami, Florida 33136
    United States

    Site Not Available

  • Orlando, Florida 32803
    United States

    Site Not Available

  • Tampa, Florida 33614
    United States

    Site Not Available

  • Atlanta, Georgia 30312
    United States

    Site Not Available

  • Decatur, Georgia 30033
    United States

    Site Not Available

  • Chicago, Illinois 60612
    United States

    Site Not Available

  • Lutherville, Maryland 21093
    United States

    Site Not Available

  • Boston, Massachusetts 02115
    United States

    Site Not Available

  • Kansas City, Missouri 64111
    United States

    Site Not Available

  • Santa Fe, New Mexico 87505
    United States

    Site Not Available

  • Bronx, New York 10468
    United States

    Site Not Available

  • New York, New York 10065
    United States

    Site Not Available

  • Chapel Hill, North Carolina 27599
    United States

    Site Not Available

  • Durham, North Carolina 27710
    United States

    Site Not Available

  • Cincinnati, Ohio 45267-0595
    United States

    Site Not Available

  • Allentown, Pennsylvania 18102
    United States

    Site Not Available

  • Philadelphia, Pennsylvania 19107
    United States

    Site Not Available

  • Providence, Rhode Island 02906
    United States

    Site Not Available

  • Dallas, Texas 75235
    United States

    Site Not Available

  • Houston, Texas 77004
    United States

    Site Not Available

  • Annandale, Virginia 22003
    United States

    Site Not Available

  • Richmond, Virginia 23298-0341
    United States

    Site Not Available

  • Seattle, Washington 98104
    United States

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.